WO2001055335A3 - Procedes et materiaux se rapportant a des polypeptides et polynucleotides semblables a des recepteurs de leucocytes de type immunoglobuline (lir) - Google Patents

Procedes et materiaux se rapportant a des polypeptides et polynucleotides semblables a des recepteurs de leucocytes de type immunoglobuline (lir) Download PDF

Info

Publication number
WO2001055335A3
WO2001055335A3 PCT/US2001/002570 US0102570W WO0155335A3 WO 2001055335 A3 WO2001055335 A3 WO 2001055335A3 US 0102570 W US0102570 W US 0102570W WO 0155335 A3 WO0155335 A3 WO 0155335A3
Authority
WO
WIPO (PCT)
Prior art keywords
seq
polynucleotides
polypeptides
mrna
lir
Prior art date
Application number
PCT/US2001/002570
Other languages
English (en)
Other versions
WO2001055335A2 (fr
Inventor
Bryan J Boyle
Chiauyun Kuo
Nancy K Mize
Dana A Haley
Matthew C Arterburn
Y Tom Tang
Ping Zhou
Chenghua Liu
Vinod Asundi
Radoje T Drmanac
George Yeung
Servando Palencia
Original Assignee
Hyseq Inc
Bryan J Boyle
Chiauyun Kuo
Nancy K Mize
Dana A Haley
Matthew C Arterburn
Y Tom Tang
Ping Zhou
Chenghua Liu
Vinod Asundi
Radoje T Drmanac
George Yeung
Servando Palencia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc, Bryan J Boyle, Chiauyun Kuo, Nancy K Mize, Dana A Haley, Matthew C Arterburn, Y Tom Tang, Ping Zhou, Chenghua Liu, Vinod Asundi, Radoje T Drmanac, George Yeung, Servando Palencia filed Critical Hyseq Inc
Priority to CA002398251A priority Critical patent/CA2398251A1/fr
Priority to AU3300301A priority patent/AU3300301A/xx
Priority to AU2001233003A priority patent/AU2001233003B2/en
Priority to JP2001561140A priority patent/JP2004524001A/ja
Priority to EP01905085A priority patent/EP1261735A4/fr
Publication of WO2001055335A2 publication Critical patent/WO2001055335A2/fr
Publication of WO2001055335A3 publication Critical patent/WO2001055335A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne des nouveaux polynucléotides et polypeptides codés par de tels polynucléotides ainsi que leurs mutants ou variants qui correspondent à un nouveau polypeptide humain sécrété semblable à un récepteur de leucocyte de type immunoglobuline. Ces polynucléotides renferment des séquences d'acide nucléique isolées de banques d'cADN préparées à partir d'une banque d'cADN préparée à partir d'un mARN de leucocyte humain (Laboratoires GIBCO) (SEQ ID NO:1, SEQ ID NO:16); d'un mARN du cerveau d'un nourrisson (Columbia University) (SEQ ID NO: 35); d'un mARN de glande mammaire humaine (Invitrogène) (SEQ ID NO: 47); et d'un mARN de moelle osseuse (Clontech) (SEQ ID NO: 63). D'autres aspects de l'invention concernent des vecteurs contenant des procédés de production de polypeptides humains sécrétés semblables à LIR, ainsi que des anticorps propres à de tels polypeptides.
PCT/US2001/002570 2000-01-25 2001-01-25 Procedes et materiaux se rapportant a des polypeptides et polynucleotides semblables a des recepteurs de leucocytes de type immunoglobuline (lir) WO2001055335A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA002398251A CA2398251A1 (fr) 2000-01-25 2001-01-25 Procedes et materiaux se rapportant a des polypeptides et polynucleotides semblables a des recepteurs de leucocytes de type immunoglobuline (lir)
AU3300301A AU3300301A (en) 2000-01-25 2001-01-25 Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides
AU2001233003A AU2001233003B2 (en) 2000-01-25 2001-01-25 Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides
JP2001561140A JP2004524001A (ja) 2000-01-25 2001-01-25 白血球免疫グロブリン受容体（ｌｉｒ様）ポリペプチドおよびポリヌクレオチドに関する方法と材料
EP01905085A EP1261735A4 (fr) 2000-01-25 2001-01-25 Procedes et materiaux se rapportant a des polypeptides et polynucleotides semblables a des recepteurs de leucocytes de type immunoglobuline (lir)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US49140400A 2000-01-25 2000-01-25
US09/491,404 2000-01-25
US49691400A 2000-02-03 2000-02-03
US09/496,914 2000-02-03
US51970500A 2000-03-07 2000-03-07
US09/519,705 2000-03-07
US56087500A 2000-04-27 2000-04-27
US09/560,875 2000-04-27
US09/524,454 2000-05-19
US64261000A 2000-08-17 2000-08-17
US09/642,610 2000-08-17
US75151800A 2000-12-29 2000-12-29
US09/751,518 2000-12-29

Publications (2)

Publication Number Publication Date
WO2001055335A2 WO2001055335A2 (fr) 2001-08-02
WO2001055335A3 true WO2001055335A3 (fr) 2002-03-07

Family

ID=46397760

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/002570 WO2001055335A2 (fr) 2000-01-25 2001-01-25 Procedes et materiaux se rapportant a des polypeptides et polynucleotides semblables a des recepteurs de leucocytes de type immunoglobuline (lir)

Country Status (4)

Country Link
EP (1) EP1261735A4 (fr)
AU (2) AU3300301A (fr)
CA (1) CA2398251A1 (fr)
WO (1) WO2001055335A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1453540A4 (fr) * 2001-11-14 2005-06-01 Immunex Corp Modulation de la fonction des lir dans le traitement de la polyarthrite rhumatoide
AU2002952993A0 (en) * 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
US20080248011A1 (en) * 2004-01-27 2008-10-09 Medical And Biological Laboratories Co., Ltd. Methods for Isolating Monocytes
CA2624135C (fr) * 2005-09-29 2015-06-30 Eisai R & D Management Co., Ltd. Molecule d'adhesion aux lymphocytes t et anticorps connexe
EP2525813B1 (fr) 2010-01-20 2017-01-04 Merck Sharp & Dohme Corp. Anticorps anti-ilt5 et fragments d'anticorps se liant à ilt5
EP2525822B1 (fr) 2010-01-20 2017-05-10 Merck Sharp & Dohme Corp. Immunorégulation par des anticorps anti-ilt5 et fragments d'anticorps se liant à ilt5
CN107002091A (zh) 2014-10-01 2017-08-01 植物保健公司 过敏反应激发子肽及其用途
JP2017532981A (ja) 2014-10-01 2017-11-09 プラント ヘルス ケア インコーポレイテッド 破壊された過敏感反応ボックスを有するエリシターペプチド及びその使用
WO2017176588A1 (fr) 2016-04-06 2017-10-12 Plant Health Care, Inc. Microbes bénéfiques pour l'administration de peptides effecteurs ou de protéines effectrices et leur utilisation
US10793608B2 (en) 2016-04-06 2020-10-06 Plant Health Care, Inc. Hypersensitive response elicitor-derived peptides and use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078962A1 (fr) * 1999-06-18 2000-12-28 Immunex Corporation Recepteur de surface de leucocyte (lsr), un adnc de la superfamille des ig exprime dans les leucocytes humains

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001509030A (ja) * 1997-01-21 2001-07-10 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Ｆｃレセプターおよびポリペプチド
WO1998045435A2 (fr) * 1997-04-10 1998-10-15 Genetics Institute, Inc. MARQUEURS SECRETES DE SEQUENCE EXPRIMEE (sEST)
US6448035B1 (en) * 1997-04-24 2002-09-10 Immunex Corporation Family of immunoregulators designated leukocyte immunoglobulin-like receptor (LIR)
US6020161A (en) * 1997-08-19 2000-02-01 Smithkline Beecham Corporation PIGR-1, a member of immunoglobulin gene superfamily
EP0905237A3 (fr) * 1997-08-25 1999-12-22 Smithkline Beecham Corporation PIGR-2 appartenant au sous-ordre des immunoglobulines
JP2002540763A (ja) * 1999-02-10 2002-12-03 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ３３個のヒト分泌タンパク質
WO2001000673A1 (fr) * 1999-06-30 2001-01-04 Millennium Pharmaceuticals, Inc. Proteines associees aux membranes et secretees, et leurs utilisations
CA2382015A1 (fr) * 1999-08-17 2001-02-22 Incyte Genomics, Inc. Proteines associees a la membrane

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078962A1 (fr) * 1999-06-18 2000-12-28 Immunex Corporation Recepteur de surface de leucocyte (lsr), un adnc de la superfamille des ig exprime dans les leucocytes humains

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1261735A4 *

Also Published As

Publication number Publication date
WO2001055335A2 (fr) 2001-08-02
EP1261735A4 (fr) 2005-04-06
CA2398251A1 (fr) 2001-08-02
AU2001233003B2 (en) 2006-02-09
AU3300301A (en) 2001-08-07
EP1261735A2 (fr) 2002-12-04

Similar Documents

Publication Publication Date Title
WO2001088092A3 (fr) Procedes et materiaux relatifs aux polypeptides et polynucleotides du type facteur des cellules souches (du type fcs)
WO2001053454A3 (fr) Procedes et elements ayant trait a des polypeptides et des polynucleotides de type recepteurs couples a une proteine g
EP1308459A3 (fr) Séquences d'ADN complementaires pleine longueur
EP1555328A3 (fr) Procédés de triage de banques d'ADN recombiné
WO2001077169A3 (fr) Methodes et materiaux relatifs a de nouveaux polypeptides et polynucleotides du type facteur de croissance des cellules-souches
EP1440981A3 (fr) ADN complementaire humaine de pleine longueur
WO2001055335A3 (fr) Procedes et materiaux se rapportant a des polypeptides et polynucleotides semblables a des recepteurs de leucocytes de type immunoglobuline (lir)
WO1994001548A3 (fr) Fragments d'acide nucleiques humains isoles du cerveau, des tissus surrenaux, du placenta ou de la moelle osseuse
WO2000000515A3 (fr) RECEPTEUR DE CHEMOKINES OBTENU A PARTIR D'UNE BIBLIOTHEQUE D'ADNc DE FOIE-RATE DE FOETUS
WO2003016468A3 (fr) Anticorps humains anti-htnfsf13b antagonistes
EP1190043A4 (fr) Glycoproteine vi et ses utilisations
GR970300026T1 (en) Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof
WO2001055336A3 (fr) Procedes et substances relatifs a des polypeptides de type cd84 et a des polynucleotides
EP1574520A3 (fr) Polypeptides et polynucléotides ressemblant à la molécule de guidage neuronale ainsi que méthodes et matériaux dérivés
CA2127117A1 (fr) Adn codant un recepteur de serotonine humain 5ht4b et son utilisation
EP1447413A3 (fr) ADN complementaire humaine de pleine longueur
WO2001053500A8 (fr) Procedes et substances relatifs a des polypeptides de type facteur de croissance de cellules souches et a des polynucleotides
UA72875C2 (uk) БІЛКИ, ЯКІ ЗВ'ЯЗУЮТЬСЯ З <font face="Symbol">b</font>-АМІЛОЇДНИМ ПЕПТИДОМ ТА ПОЛІНУКЛЕОТИДИ, ЩО ЇХ КОДУЮТЬ
WO2000004041A3 (fr) Procedes et materiaux associes a de nouveaux polypeptides semblables a cd39
WO2001075064A3 (fr) Methode et materiels relatifs a des polypeptides et a des polynucleotides semblables a la proteine de liaison au facteur de croissance semblable a l'insuline
WO2003040326A3 (fr) Polypeptides et polynucleotides de type prokineticine, procedes et materiaux associes
WO2001053456A3 (fr) Procedes et substances relatifs a des polypeptides de type prothrombinase et a des polynucleotides
IL122884A0 (en) Enamel matrix related polypeptide
WO2002022780A3 (fr) Procedes et materiaux associes au polypeptide et aux polynucleotides similaires a la neuropiline
WO2004007672A3 (fr) Procede et materiaux se rapportant a de nouveaux polypeptides et polynucleotides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001905085

Country of ref document: EP

Ref document number: 2398251

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2001 561140

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2001233003

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2001905085

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2001233003

Country of ref document: AU